Loading...
Cirrhotic patients who suffer from variceal hemorrhage have a 60% risk for rebleeding within 1 year and a 20% mortality risk related to each bleeding episode. Band ligation is the preferred endoscopic treatment for hemorrhage in these patients and is effective in preventing rebleeding. Beta-blocker monotherapy also reduces rebleeding by lowering portal pressures. Several studies have suggested that the combination of endoscopic and beta-blocker therapy is more effective in reducing rebleed rates than is either therapy alone, but that it does not improve survival. Despite the lack of survival benefit, combination therapy is endorsed in joint practice guidelines from the American Association for the Study of Liver Diseases and the American Co…